Company Announcement no. 11/2020
To: NASDAQ Copenhagen A/S
Notice to Convene Extraordinary General Meeting
Upon request from Asahi Kasei Pharma Denmark A/S, the board of directors of
Monday
at the offices of Plesner Law Firm, Amerika Plads 37, 2100
Shareholders who have accepted the voluntary recommended public offer shall disregard this convening notice as such shareholders have no rights to attend and vote at the Extraordinary General Meeting as their shares are sold.
Agenda
1 Election of new members of the board of directors of
Please see attached document for complete proposals.
For more information, please contact:
Craig A. Collard
President & CEO CFO
Phone: +1 919 591 3090 Phone: +1 919 591 3090
Email: cac@veloxis.com Email: idu@veloxis.com
Attachment
- Notice to convene - Extraordinary general meeting
17 February 2020 -Veloxis Pharmaceuticals
© OMX, source